Grantham, Mayo, Van Otterloo & Co (GMO)
NVMI

Grantham, Mayo, Van Otterloo & Co (GMO)’s Nova NVMI Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio NVMI Stock Details NVMI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-802
Closed -$268K – 698
2025
Q4 		$268K Buy
+802
New +$258K ﹤0.01% 621

Other funds holding NVMI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
UIM
USS Investment Management London, United Kingdom $27.8B AUM 39.42% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO)'s NVMI Position: Q1 2026 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of Nova (NVMI) in Q1 2026, closing a stake of 802 shares — an estimated $268K sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in NVMI in Q4 2025 and held it in 1 quarter. The position peaked at $268K in Q4 2025. 330 funds tracked by Wall St. Rank hold NVMI as of Q1 2026.

  • Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining Nova position as of Q1 2026 after selling out during the quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 802 Nova shares in Q1 2026, an estimated $268K.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Nova in Q4 2025 and held it in 1 quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s Nova position peaked at $268K in Q4 2025.
  • 330 funds tracked by Wall St. Rank held Nova as of Q1 2026.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q1 2026, filed 14 May 2026.